Filing Details
- Accession Number:
- 0001567619-22-020130
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-14 17:00:11
- Reporting Period:
- 2022-11-10
- Accepted Time:
- 2022-11-14 17:00:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1740719 | V Kathy Turner | One Idexx Drive Westbrook ME 04092 | Senior Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-11-10 | 5,310 | $206.94 | 12,233 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-11-10 | 2,655 | $410.02 | 9,578 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-10 | 25 | $406.11 | 9,553 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-10 | 2,630 | $405.21 | 6,923 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-11-11 | 8,567 | $178.26 | 15,490 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-11-11 | 2,567 | $442.05 | 12,293 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-11 | 3,000 | $438.00 | 9,923 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-11-11 | 3,000 | $436.06 | 6,923 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2022-11-10 | 5,310 | $0.00 | 5,310 | $206.94 |
| Common Stock | Non-Qualified Stock Option (right-to-buy) | Disposition | 2022-11-11 | 8,567 | $0.00 | 8,567 | $178.26 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,056 | 2029-02-13 | No | 4 | M | Direct | |
| 1,581 | 2028-02-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 100 | Indirect | by spouse |
Footnotes
- Includes a total of 37 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2022, June 30, 2022 and, September 30, 2022.
- Represents the weighted average price of the shares sold ranging from a low of $410.00 to a high of $410.35 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $406.10 to a high of $406.115 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $405.00 to a high of $405.87 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $442.00 to a high of $442.0125 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Represents the weighted average price of the shares sold ranging from a low of $435.00 to a high of $435.21 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- The reporting person disclaims beneficial interest of the shares of common stock held by her spouse except to the extent of her pecuniary interest therein.
- Grant of option to buy shares of Issuer common stock that vest in five annual installments beginning February 14, 2020.
- Grant of option to buy shares of Issuer common stock that vest in five annual installments beginning February 14, 2019.
- Not applicable.
Billionaire Hedge Funds
